Many sources report that India's first indigenous vaccine for battling the Coronavirus that caused the 21st pandemic will be available to the public by next month on Independence Day. India declared nation-wide lockdown on 18 March 2020 evening. The lockdown has been in place for about 3 months and many cities are suffering the worse. While some big cities like Mumbai, Delhi, and Chennai have not recovered from the spread of the virus, some states managed to control the virus spread and the treatment.
Today, many sources say that India is developing the vaccine using BBV152 COVID immunization. The Indian Council of Medical Research (ICMR) has announced that it is planning to fast track the human clinical trials of coronavirus vaccine which is being developed in partnership with Bharat Biotech International Limited (BBIL).
"The vaccine is being derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine", ICMR Director General Balram Bhargava said.
Bhubaneswar's IMS and SUM Hospital, the other institutes selected for the clinical trial are located in Visakhapatnam, Rohtak, New Delhi, Patna, Belgaum (Karnataka), Nagpur, Gorakhpur, Kattankulathur (Tamil Nadu), Hyderabad, Arya Nagar, Kanpur (Uttar Pradesh) and Goa are the 10 institutes asked by the ICMR to fast track clinical trials of the vaccine. This is considered as one of the top priority projects monitored by the central government.